Amrutanjan Health Care Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
AMRUTANJAN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Amrutanjan Health Care has informed the stock exchanges that the trading window for dealing in its securities will be closed for designated persons from October 1, 2025 until 48 hours after the declaration of its Unaudited Financial Results for the quarter ending September 30, 2025 (Q2 FY26). This action is being taken in line with SEBI's Prohibition of Insider Trading Regulations, 2015, and the company's internal code of conduct. Designated persons have been asked not to trade in the company's shares during this restricted period. The intimation was filed by the Company Secretary & Compliance Officer on September 26, 2025.
This is a routine compliance filing and does not directly affect shareholders. However, it signals that the company's Q2 FY26 results are expected to be announced in the coming weeks, which could be a catalyst for stock price movement.